Revelation Biosciences, Inc., (REVB) Social Stream



Revelation Biosciences, Inc., (REVB): $1.83

0.08 (-4.19%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add REVB to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#269 of 360

in industry

REVELATION BIOSCIENCES INC (REVB) Price Targets From Analysts

Use the tables below to see what analysts covering REVELATION BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-17 1 $12 $12 $12 $0.47 2453.19%
2022-05-16 1 $9 $9 $9 $0.47 1814.89%
2022-10-07 1 $174.825 $174.825 $174.825 $0.47 37096.81%
2023-05-22 1 $15 $15 $15 $0.47 3091.49%
2023-11-14 1 $15 $7.9 $11.45 $0.47 2336.17%

Price Target Last Issued October 7, 2022

The Trend in the Analyst Price Target


REVB's average price target has moved down $3.55 over the prior 39 weeks.

REVB reports an average of 1,149.84% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-14 1 15 15.0 15.00 2.700 455.56%
2023-05-22 1 15 15.0 15.00 1.190 1160.5%
2023-06-22 1 15 7.9 11.45 1.040 1000.96%
2023-08-14 1 15 7.9 11.45 0.731 1466.35%
2023-11-14 1 15 7.9 11.45 0.615 1761.79%

REVB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


REVB's average broker recommendation rating improved by 0 over the prior 39 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • REVB has a greater number of analysts covering the stock than just about none of of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, REVELATION BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 593.26% of them.
  • REVB has a lower variance in analysts' estimates than 25.55% of stocks in the micro market cap category.
  • To contextualize these metrics, consider that out of Healthcare stocks, REVELATION BIOSCIENCES INC's average analyst price target is higher than 176.69% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to REVELATION BIOSCIENCES INC are VIRI, BPTS, and VRPX.

Make investment decisions regarding REVB using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!